- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07293689
PREcision MEDicine In Achalasia (PREMEDIA) - Kohorte (PREMEDIA)
PREcision MEDicin ved Achalasia - Et Multicenter Randomiseret Non-Inferioritets Klinisk Studie af Kort Skræddersyet POEM vs. Standard POEM for Ikke-Spastisk Achalasia og Et Multicenter Prospektivt Kohortestudie af Lang Skræddersyet POEM for Spastiske Spiserørsbevægelighedsforstyrrelser
The goal of this observational study is to learn about how the doctor decides how long to cut t the esophageal muscle during Per-Oral Endoscopic Myotomy (POEM) in patients with difficulty swallowing due to certain conditions. The main question it aims to answer is: does pre-POEM testing help the physician choose how long to cut the muscle.
Participants will allow researchers to access their standard of care information in their medical record, complete questionnaires at up to 6 times over a 2-year period.
Studieoversigt
Status
Undersøgelsestype
Tilmelding (Anslået)
Kontakter og lokationer
Studiekontakt
- Navn: Elizabeth Yan, BS
- Telefonnummer: 312-908-1723
- E-mail: premedia.dcc@northwestern.edu
Undersøgelse Kontakt Backup
- Navn: Yasmin Pina, BS
- Telefonnummer: 312-503-6459
- E-mail: premedia.dcc@northwestern.edu
Studiesteder
-
-
Arizona
-
Scottsdale, Arizona, Forenede Stater, 85259
- Ikke rekrutterer endnu
- Mayo Clinic Arizona
-
-
California
-
La Jolla, California, Forenede Stater, 92037
- Rekruttering
- University of California San Diego
-
Ledende efterforsker:
- Rena Yadlapati, MD
-
Kontakt:
- Alexander Gonsalves, Lead Study Coordinator
- Telefonnummer: 858-246-5236
- E-mail: PREMEDIA@health.ucsd.edu
-
-
Colorado
-
Denver, Colorado, Forenede Stater, 80217
- Ikke rekrutterer endnu
- University of Colorado Denver
-
-
Florida
-
Gainesville, Florida, Forenede Stater, 32611
- Rekruttering
- University of Florida
-
Ledende efterforsker:
- Peter Draganov, MD
-
Kontakt:
- April Goddard, Lead Study Coordinator, PA-C
- Telefonnummer: 352-273-9483
- E-mail: DOM-GIResereachTeam@ad.ufl.edu
-
Orlando, Florida, Forenede Stater, 32803
- Ikke rekrutterer endnu
- Adventist Health System/Sunbelt, Inc
-
-
Georgia
-
Atlanta, Georgia, Forenede Stater, 30322
- Rekruttering
- Emory University
-
Ledende efterforsker:
- Anand Jain, MD
-
Kontakt:
- Halley Fowler, Lead Study Coordinator
- Telefonnummer: 404-778-3184
- E-mail: halley.fowler@emory.edu
-
-
Illinois
-
Chicago, Illinois, Forenede Stater, 60611
- Rekruttering
- Northwestern University
-
Ledende efterforsker:
- John Pandolfino, MD
-
Kontakt:
- Eric Pfannkuche, Lead Study Coordinator
- Telefonnummer: 312-926-4525
- E-mail: PREMEDIA@northwestern.edu
-
-
Maryland
-
Baltimore, Maryland, Forenede Stater, 21218
- Ikke rekrutterer endnu
- Johns Hopkins University
-
-
Massachusetts
-
Boston, Massachusetts, Forenede Stater, 02114
- Rekruttering
- Massachusetts General Hospital
-
Kontakt:
- Madison Paylor, Lead Study Coordinator
- Telefonnummer: 617-726-0196
- E-mail: premedia@mgb.org
-
Ledende efterforsker:
- Kyle Staller, MD
-
-
Missouri
-
St Louis, Missouri, Forenede Stater, 63110
- Rekruttering
- Washington University
-
Kontakt:
- Darren Nix, Lead Study Coordinator
- Telefonnummer: 314-273-1432
- E-mail: Premediasurgerytrial@wustl.edu
-
Ledende efterforsker:
- Chandra Gyawali, MD
-
-
New York
-
New York, New York, Forenede Stater, 10065
- Ikke rekrutterer endnu
- Weill Cornell Medical College
-
-
North Carolina
-
Charlotte, North Carolina, Forenede Stater, 28204
- Rekruttering
- Atrium Health/Wake Forest
-
Ledende efterforsker:
- Badih Elmunzer, MD
-
Kontakt:
- Greg Scarola, Lead Study Coordinator
- Telefonnummer: (704) 355-2000
- E-mail: PREMEDIA@advocatehealth.org
-
-
Ohio
-
Cleveland, Ohio, Forenede Stater, 44109
- Rekruttering
- MetroHealth Medical Center
-
Ledende efterforsker:
- Ronnie Fass, MD
-
Kontakt:
- Stephanie Baker, Lead Study Coordinator
- Telefonnummer: 216-778-5736
- E-mail: premedia@metrohealth.org
-
Cleveland, Ohio, Forenede Stater, 44106
- Ikke rekrutterer endnu
- Case Western Reserve University
-
-
Tennessee
-
Nashville, Tennessee, Forenede Stater, 37232
- Rekruttering
- Vanderbilt University Medical Center
-
Ledende efterforsker:
- Dhyanesh Patel, MD
-
Kontakt:
- Larry Raber, Lead Study Coordinator
- Telefonnummer: 615-322-4643
- E-mail: larry.w.raber@vumc.org
-
-
Texas
-
Dallas, Texas, Forenede Stater, 75246
- Rekruttering
- Baylor Scott & White Health
-
Kontakt:
- Neomy Flores, Lead Study Coordinator
- Telefonnummer: 214-820-9704
- E-mail: premedia@bswhealth.org
-
Ledende efterforsker:
- Vani Albertson Konda, MD
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Achalasia, EGJOO, and other spastic motility disorders are relatively rare and have substantial quality of life implications (see Protocol and Research Strategy for details). Given the prevalence and severity of these conditions, it is uncommon for patients with symptoms to not seek some form of treatment. Thus, we expect much of the recruitment to occur directly from site clinics, which include prominent esophageal motility experts and have robust referral networks, as patients seek care. A review of POEM procedure logs from participating CCs reveals that likely eligible patients are on average about 55-65 years old. We anticipate that the ethnic and racial distribution of our study group will be similar to prior achalasia studies with 25% African American, 10% Hispanic and 65% Caucasian.
Beskrivelse
Inclusion Criteria:
- Age ≥ 18
- Type III achalasia or EGJOO with spastic/hypercontractile features or Jackhammer Esophagus or Distal Esophageal Spasm
- Eckardt Score > 3
Exclusion Criteria:
-
Exclusion:
- Prior POEM
- Prior surgical treatment for achalasia
- Endoscopic pneumatic dilation or lower esophageal sphincter botulinum toxin (botox) injection within 6 months
- Prior unrelated esophageal or upper gastric surgery, including Roux-en-Y gastric bypass and sleeve gastrectomy
- Prior endoscopic gastroesophageal intervention for obesity or GERD, such endoscopic sleeve gastroplasty or transoral incisionless fundoplication
- Known secondary achalasia related to malignancy (pseudoachalasia)
- Known eosinophilic esophagitis
- Diverticulum (> 2 cm) in distal esophagus
- Megaesophagus
- Fibroinflammatory stricture of the esophagus due to any etiology (e.g., peptic, radiation, eosinophilic)
- Pregnancy
- Standard contraindications to general anesthesia
- Standard contraindications to endoscopic myotomy in the esophagus (e.g. untreated varices)
- Unwillingness or inability to consent for the study
- Anticipated inability to follow protocol
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: CASE_ONLY
- Tidsperspektiver: PROSPECTIVE
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Clinical Response-Overall
Tidsramme: From enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From enrollment to Year 2
|
|
Clinical Response-by Sex
Tidsramme: From enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From enrollment to Year 2
|
|
Clinical Response-by Race
Tidsramme: From Enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From Enrollment to Year 2
|
|
Clinical Response-by Ethnicity
Tidsramme: From Enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From Enrollment to Year 2
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- PREMEDIA (Pro00083748) - 02
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-deling Understøttende informationstype
- STUDY_PROTOCOL
- SAP
- CSR
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .